BR9900114A - Composições de ciclodextrina. - Google Patents

Composições de ciclodextrina.

Info

Publication number
BR9900114A
BR9900114A BR9900114-4A BR9900114A BR9900114A BR 9900114 A BR9900114 A BR 9900114A BR 9900114 A BR9900114 A BR 9900114A BR 9900114 A BR9900114 A BR 9900114A
Authority
BR
Brazil
Prior art keywords
cyclodextrin compositions
cyclodextrin
compositions
milbemycin
avermectin
Prior art date
Application number
BR9900114-4A
Other languages
English (en)
Inventor
David Ringshaw
Ninh On
Philip Edward Moss
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9900114A publication Critical patent/BR9900114A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Patente de Invenção:<B>"COMPOSIçõES DE CICLODEXTRINA"<D>. A presente invenção refere-se a uma composição farmacêutica, que compreende pelo menos um composto anti-helminticamente ativo que é uma avermectina ou milbemicina, na forma de um complexo com pelo menos uma ciclodextrina.
BR9900114-4A 1998-01-20 1999-01-19 Composições de ciclodextrina. BR9900114A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9801109.1A GB9801109D0 (en) 1998-01-20 1998-01-20 Cyclodextrin compositions

Publications (1)

Publication Number Publication Date
BR9900114A true BR9900114A (pt) 2000-05-02

Family

ID=10825529

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9900114-4A BR9900114A (pt) 1998-01-20 1999-01-19 Composições de ciclodextrina.

Country Status (11)

Country Link
US (1) US20020032161A1 (pt)
EP (1) EP0930077B1 (pt)
JP (2) JPH11255646A (pt)
AT (1) ATE237359T1 (pt)
BR (1) BR9900114A (pt)
CA (1) CA2259699A1 (pt)
DE (1) DE69813496T2 (pt)
DK (1) DK0930077T3 (pt)
ES (1) ES2194279T3 (pt)
GB (1) GB9801109D0 (pt)
PT (1) PT930077E (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091192B1 (en) * 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
BRPI0200751B1 (pt) * 2002-02-06 2018-10-23 Univ Minas Gerais complexos de inclusão de benzaldeído semicabazona em ciclodextrinas e seu método de preparação
CN102516417B (zh) 2002-09-06 2014-12-10 天蓝制药公司 用于传递治疗剂的以环糊精为基础的聚合物
WO2005014010A1 (en) * 2003-07-24 2005-02-17 Eli Lilly And Company Pharmaceutical composition comprising gemcitabine and cyclodextrines
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
EP2219643B1 (en) 2007-11-15 2012-05-16 Novartis AG Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
CN104208716A (zh) * 2009-11-23 2014-12-17 天蓝制药公司 用于传递治疗剂的基于环糊精的聚合物
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN104208017A (zh) * 2013-05-29 2014-12-17 镇江威特药业有限责任公司 一种伊维菌素溶液及其制备方法
FR3042412A1 (fr) * 2015-10-14 2017-04-21 Biotopic Pharmaceuticals Formulation pharmaceutique stabilisee et prete a l'emploi d'ivermectine dans le traitement des parasitoses humaines et animales
AU2017363131B2 (en) * 2016-11-16 2020-01-16 Aivita Biomedical, Inc. Use of cell membrane-bound signaling factors
CA3082803A1 (en) 2017-11-16 2019-05-23 Aivita Biomedical, Inc. Use of cell membrane-bound signaling factors
CN108982883A (zh) * 2018-07-16 2018-12-11 上海海洋大学 一种预测鲜切生菜货架期模型
WO2022034226A1 (en) 2020-08-14 2022-02-17 Universidad De Navarra Avermectin and milbemycin compositions for inhalation
US11077134B1 (en) * 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11253533B1 (en) * 2020-11-10 2022-02-22 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69619894T2 (de) * 1995-06-30 2002-11-14 American Cyanamid Co., Madison Stabile Makrolide und Makrolide Imptstoff-Zusammensetzungen

Also Published As

Publication number Publication date
ES2194279T3 (es) 2003-11-16
PT930077E (pt) 2003-07-31
DK0930077T3 (da) 2003-08-04
DE69813496D1 (de) 2003-05-22
EP0930077A1 (en) 1999-07-21
US20020032161A1 (en) 2002-03-14
EP0930077B1 (en) 2003-04-16
JP2006083186A (ja) 2006-03-30
DE69813496T2 (de) 2003-10-30
ATE237359T1 (de) 2003-05-15
JPH11255646A (ja) 1999-09-21
CA2259699A1 (en) 1999-07-20
GB9801109D0 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
BR9900114A (pt) Composições de ciclodextrina.
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
BR0111222A (pt) Derivados fosfonados de glicopeptìdeo
TR199701484T1 (xx) Endoparazit �ld�r�c� bile�im.
BR9810495A (pt) Composição farmacêutica
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
EE200000759A (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
AR010375A1 (es) Composiciones endo-ectoparasiticidas
PE20011289A1 (es) Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
PT842934E (pt) Agonistas de 5-ht1f
BR0215392A (pt) Composições farmacêuticas compreendendo um inibidor de fosfodiesterase multifuncional e um inibidor de absorção de adenosina, bem como uso das mesmas
ES2129078T3 (es) Preparacion farmaceutica que comprende un compuesto capaz de degradar los antibioticos beta-lactamicos y su utilizacion.
BR0014775B1 (pt) misturas antimicrobianas de 1,3-bis (hidroximetil) -5,5-dimetilidantoina e 1,2-benzisotiazolin-3-ona.
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ATE388960T1 (de) Glykopeptidderivate mit carboxysacchariden
EP1834670A3 (en) Anthelmintic compositions containing combinations of avermectins or milbemycins with bis-aryl compounds
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DE69936052D1 (de) N1 modifizierte glycopeptide
ES2164660T3 (es) Derivados difluoro de avermectina.
TR199901017A2 (xx) B�cek ilac� terkibi.
PT1142905E (pt) Novo composto de depsipeptido
BR0104352A (pt) Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 47/48, A61K 31/366, A61P 33/10, A61K 47/40

Ipc: A61K 47/48 (2007.10), A61K 31/366 (2007.10), A61P

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/7048 (2006.01), A61K 31/365 (2006.0